+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Insomnia Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4620323
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • F.Hoffman La-Roche AG
  • Merck & Co. Inc.
  • Mylan N.V.
  • Pernix Therapeutics
  • Pfizer, Inc.
  • Sanofi S.A.
  • MORE
Insomnia Treatment Drugs Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026, the global insomnia treatment drugs market was valued at US$ 2,689.6 Mn in 2017, and is expected to reach US$ 4,332.4 Mn by 2026, expanding at a CAGR of 5.5% from 2018 to 2026.

Market Insights
As per the scientific evidences reported by American Psychiatric Association (APA) approximately one third of the adults suffer with insomnia during their lifetime. It is manifested by incessant problems in falling and staying asleep. Patients suffering with insomnia experience symptoms such as fatigue, mood disturbances, lack of concentration, low productivity, loss of appetite etc. Pharmaceutical companies are relentlessly working to provide effective medication with least side effects. Orexin antagonist (Belsomra) are being prescribed by physicians throughout the globe owing to its ability to improve sleep with high degree of tolerability and limited adverse effects profile. The insomnia treatment drugs market pose severe threat from alternative treatment such as cognitive behavioral therapy for insomnia (CBTI) and recent FDA approval of devices such as Fisher Wallace Stimulator and EBB Insomnia Therapy.

Prescription sleep aids dominate the treatment type segment on account of key factors such as rising prevalence of insomnia, increasing stress, addiction etc., which if untreated will eventually result in chronic illness. Demanding lifestyle and poor sleeping habits result in secondary insomnia which requires benzodiazepines in combination with zolpidem for its treatment. Antidepressants are prescribed for patients suffering with neuropsychiatric ailment. Over the counter sleep aids comprises of antihistamines, melatonin and dietary supplement. Antihistamine and melatonin are utilized to produce sedative effect in patients suffering with altered circadian rhythm and jet lag. Dietary supplements are usually taken by patients to stimulate the production of melatonin by pineal gland.

Currently North America is leading the regional segment for insomnia treatment drugs market. Increasing number of geriatric population suffering with sleep disorders and rising prevalence of addiction and stress in the youth drive the insomnia treatment drugs market in North America. Asia Pacific is anticipated to exhibit steady growth during the forecast period owing to the rising prevalence of insomnia in patients suffering with chronic pain, hypertension, anxiety etc. Accurate diagnosis of insomnia has spurred the pharmaceutical companies to manufacture generic drugs in abundant quantity to cater the medicinal requirements of the huge patient base in the Asia Pacific region.
The key players actively engaged in the insomnia treatment drugs market are Merck & Co. Inc., F.Hoffman La-Roche AG, Mylan N.V., Pernix Therapeutics, Pfizer, Inc., Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co. Ltd., Teva Phamaceutical Industries Ltd, and Vanda Pharmaceuticals, Inc.

Key Market Movements:
  • Increasing number of geriatric population suffering with sleep disorders in the developed nations
  • Affordable reimbursement scenario for drugs prescribed in insomnia treatment
  • Growing health awareness leading to effective insomnia treatment, and developing healthcare infrastructure drive the market growth in developing nations
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • F.Hoffman La-Roche AG
  • Merck & Co. Inc.
  • Mylan N.V.
  • Pernix Therapeutics
  • Pfizer, Inc.
  • Sanofi S.A.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Insomnia Treatment Drugs Market Portraiture
2.2. Global Insomnia Treatment Drugs Market, by Treatment Type, 2017 (US$ Mn)
2.3. Global Insomnia Treatment Drugs Market, by Geography, 2017 (US$ Mn)

Chapter 3. Insomnia Treatment Drugs Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Insomnia Treatment Drugs Market, by Key Players, 2017

Chapter 4. Global Insomnia Treatment Drugs Market, by Treatment Type
4.1. Overview
4.2. Prescription Sleep Aids
4.2.1. Benzodiazepine
4.2.2. Antidepressant
4.2.3. Orexin Antagonist
4.3. Over the Counter (OTC) Sleep Aids
4.3.1. Antihistamines
4.3.2. Melatonin
4.3.3. Dietary Supplement

Chapter 5. Global Insomnia Treatment Drugs Market, by Geography
5.1. Overview
5.2. North America Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.2.1. North America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Insomnia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.3.1. Europe Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.5.1. Latin America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.6.1. MEA Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Insomnia Treatment Drugs Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. F.Hoffman La-Roche AG
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Merck & Co. Inc.
6.3. Mylan N.V.
6.4. Pernix Therapeutics
6.5. Pfizer, Inc.
6.6. Sanofi S.A.
6.7. Sumitomo Dainippon Pharma Co., Ltd
6.8. Takeda Pharmaceutical Company Ltd.
6.9. Teva Pharmaceutical Industries Ltd.
6.10. Vanda Pharmaceuticals, Inc.

List of Figures:
Figure. 1 Insomnia Treatment Drugs Market: Research Methodology
Figure. 2 Insomnia Treatment Drugs: Market Segmentation
Figure. 3 Global Insomnia Treatment Drugs Market, by Treatment Type, 2017 (US$ Mn)
Figure. 4 Global Insomnia Treatment Drugs Market, by Geography, 2017 (US$ Mn)
Figure. 5 Attractive Investment Proposition: by Geography, 2017
Figure. 6 Competitive Analysis: Global Insomnia Treatment Drugs Market, by Key Players, 2017
Figure. 7 Global Benzodiazepine Drugs Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
Figure. 8 Global Antidepressant Drugs Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
Figure. 9 Global Orexin Antagonist Drugs Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
Figure. 10 Global Antihistamine Drugs Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
Figure. 11 Global Melatonin Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
Figure. 12 Global Dietary Supplements Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
Figure. 13 U.S. Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 14 Canada Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 15 U.K. Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 16 Germany Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 17 Rest of Europe Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 18 China Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 19 Japan Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 20 Rest of Asia Pacific Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 21 Brazil Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 22 Mexico Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 23 Rest of Latin America Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 24 GCC Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
Figure. 25 Rest of Middle East and Africa Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)

List of Tables:
Table 1 Global Insomnia Treatment Drugs Market Portraiture
Table 2 Global Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
Table 3 Global Prescription Sleep Aids Market for Insomnia Treatment, by Treatment Type, 2016 – 2026 (US$ Mn)
Table 4 Global OTC Sleep Aids Market for Insomnia Treatment, by Treatment Type, 2016 – 2026 (US$ Mn)
Table 5 Global Insomnia Treatment Drugs Market, by Geography, 2016 – 2026 (US$ Mn)
Table 6 North America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
Table 7 North America Insomnia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
Table 8 Europe Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
Table 9 Europe Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 10 Asia Pacific Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
Table 11 Asia Pacific Insomnia Treatment Drugs Market, by Country/Region, 2015 – 2025 (US$ Mn)
Table 12 Latin America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
Table 13 Latin America Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 14 Middle East and Africa Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
Table 15 Middle East and Africa Insomnia Treatment Drugs Market, by Region, 2016 – 2026 (US$ Mn)
Table 16 F.Hoffman La-Roche AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 17 Merck & Co. Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 18 Mylan N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 19 Pernix Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 20 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 21 Sumitomo Dainippon Pharma Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 22 Takeda Pharmaceuticals Company Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 23 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 24 Vanda Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F.Hoffman La-Roche AG
  • Merck & Co. Inc.
  • Mylan N.V.
  • Pernix Therapeutics
  • Pfizer, Inc.
  • Sanofi S.A.
  • Sumitomo Dainippon Pharma Co., Ltd
  • Takeda Pharmaceutical Company Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vanda Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4620323
Adroll
adroll